cemka > Publications > Infectiologie

Classer les publications sur l'année

  • SantĂ© publique

    PrĂ©vac B: prĂ©vention de l’hĂ©patite B dans les populations migrantes originaires de zones de forte endĂ©mie, Afrique subsaharienne et Asie

    AUBERT JP, CATRICE M, BOUEE S, DI PUMPO A, SANTANA P, GERVAIS A, WAJSBROT A, GELLY J, NOUGAIREDE M

    Revue du Praticien (supplément) ; 2010;60:13-20

  • Économie de la santĂ©

    Modelling the budget impact of Darunavir in the treatment of highly treatment-experienced, HIV-Infected adults in France

    COLIN X, LAFUMA A, COSTAGLIOLA D, SMETS E, MAUSKOPF J, GUILLON P

    Pharmacoeconomics ; 2010;28(S1):183-197

  • Économie de la santĂ©

    Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States

    YE X, RUPNOW M, BASTIDE P, LAFUMA A, OVINGTON L, JARVIS WR

    Am J Infect Control ; 2011;39(8):647-654

  • Pharmaco-EpidĂ©miologie

    Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)

    BOURLIERE M, OUZAN D, ROSENHEIM M, DOFFOËL M, MARCELLIN P, PAWLOTSKY JM, SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY M
    SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY M

    Antivir Ther ; 2012;17(1):101-110

  • Pharmaco-EpidĂ©miologie

    Feasibility and acceptability of rapid HIV test screening (DEPIVIH) by French family physicians

    GAUTHIER R, LIVROZET JM, PREVOTEAU DU CLARY F, TAULERA O, BOUEE S, AUBERT JP, PY AM , PETER JM, MAJERHOLC C, HÉBER SUFFRIN S, COMPAGNON C, WAJSBROT  A

    Med Mal Infect ; 2012;42:553-560